Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Hepatitis C and HIV infection: biological, clinical, and therapeutic implications
Autore:
Soriano, V; Garcia-Samaniego, J; Rodriguez-Rosado, R; Gonzalez, J; Pedreira, J;
Indirizzi:
Hosp Carlos 3, Inst Salud Carlos III, Infect Dis Serv, Madrid, Spain Hosp Carlos 3 Madrid Spain d Carlos III, Infect Dis Serv, Madrid, Spain Hosp Carlos 3, Inst Salud Carlos III, Hepatol Unit, Madrid, Spain Hosp Carlos 3 Madrid Spain alud Carlos III, Hepatol Unit, Madrid, Spain Hosp La Paz, HIV Unit, Madrid, Spain Hosp La Paz Madrid SpainHosp La Paz, HIV Unit, Madrid, Spain Infect Dis Unit, La Coruna, Spain Infect Dis Unit La Coruna SpainInfect Dis Unit, La Coruna, Spain
Titolo Testata:
JOURNAL OF HEPATOLOGY
, volume: 31, anno: 1999, supplemento:, 1
pagine: 119 - 123
SICI:
0168-8278(1999)31:<119:HCAHIB>2.0.ZU;2-K
Fonte:
ISI
Lingua:
ENG
Soggetto:
HUMAN-IMMUNODEFICIENCY-VIRUS; DYNAMICS IN-VIVO; PROTEASE INHIBITORS; INTERFERON-ALPHA; NATURAL-HISTORY; LIVER-DISEASE; HEMOPHILIACS; COINFECTION; PROGRESSION; RIBAVIRIN;
Keywords:
hepatitis C; HIV; interferon; liver disease; ribavirin;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
33
Recensione:
Indirizzi per estratti:
Indirizzo: Soriano, V C-Rafael Calvo 7,2A, Madrid 28010, Spain C-Rafael Calvo 7,2A Madrid Spain 28010 A, Madrid 28010, Spain
Citazione:
V. Soriano et al., "Hepatitis C and HIV infection: biological, clinical, and therapeutic implications", J HEPATOL, 31, 1999, pp. 119-123

Abstract

As deaths from AIDS continue to decline in HIV-infected persons, liver disease is becoming an increasing cause of hospital admission and death in HIV-HCV co-infected persons. The problem is particularly relevant among intravenous drug users and haemophiliacs, most of whom are co-infected. Moreover,the risk of hepatotoxicity is higher with anti-HIV drugs among patients with chronic hepatitis C. Treatment with alpha-interferon provides a similar rate of response in non-severely immunosuppressed HIV-positive subjects as in HIV-negatives, and preliminary results from trials using the combinationof interferon plus ribavirin in HIV-HCV co-infection look very promising for both rates of sustained response and safety.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/03/20 alle ore 09:57:49